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Abstract
Background: Engineered nanoparticles are becoming increasingly ubiquitous and their toxicological effects on human
health, as well as on the ecosystem, have become a concern. Since initial contact with nanoparticles occurs at the
epithelium in the lungs (or skin, or eyes), in vitro cell studies with nanoparticles require dose-controlled systems for
delivery of nanoparticles to epithelial cells cultured at the air-liquid interface.
Results: A novel air-liquid interface cell exposure system (ALICE) for nanoparticles in liquids is presented and validated.
The ALICE generates a dense cloud of droplets with a vibrating membrane nebulizer and utilizes combined cloud settling
and single particle sedimentation for fast (~10 min; entire exposure), repeatable (<12%), low-stress and efficient delivery
of nanoparticles, or dissolved substances, to cells cultured at the air-liquid interface. Validation with various types of
nanoparticles (Au, ZnO and carbon black nanoparticles) and solutes (such as NaCl) showed that the ALICE provided
spatially uniform deposition (<1.6% variability) and had no adverse effect on the viability of a widely used alveolar human
epithelial-like cell line (A549). The cell deposited dose can be controlled with a quartz crystal microbalance (QCM) over
a dynamic range of at least 0.02-200 μg/cm2. The cell-specific deposition efficiency is currently limited to 0.072 (7.2% for
two commercially available 6-er transwell plates), but a deposition efficiency of up to 0.57 (57%) is possible for better
cell coverage of the exposure chamber.
Dose-response measurements with ZnO nanoparticles (0.3-8.5 μg/cm2) showed significant differences in mRNA
expression of pro-inflammatory (IL-8) and oxidative stress (HO-1) markers when comparing submerged and air-liquid
interface exposures. Both exposure methods showed no cellular response below 1 μg/cm2 ZnO, which indicates that
ZnO nanoparticles are not toxic at occupationally allowed exposure levels.
Conclusion: The ALICE is a useful tool for dose-controlled nanoparticle (or solute) exposure of cells at the air-liquid
interface. Significant differences between cellular response after ZnO nanoparticle exposure under submerged and air-
liquid interface conditions suggest that pharmaceutical and toxicological studies with inhaled (nano-)particles should be
performed under the more realistic air-liquid interface, rather than submerged cell conditions.
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Humans and other organisms are constantly exposed to a
diverse set of exogenous substances. Ambient and occupa-
tional exposure to gases and particles are recognized as
severe health risks, mainly via the lungs (inhalation), but
also potentially via the skin or even the eyes [1]. In addi-
tion, the increasingly wide-spread use of engineered nan-
oparticles (diameter <100 nm in at least one dimension;
there are currently standardization efforts under way (e.g.
ONR CEN ISO/TS 27687:2009-06-01) applying this defi-
nition to "nanoobjects"), for medical imaging, new drug
delivery technologies and various industrial products
(such as sun screen, paint and water-proof clothing), for
example, has also raised concern about the ecotoxicologi-
cal and health impact of these nanoparticles [2-4]. For
these types of particles, controlled exposure occurs via the
skin, gastrointestinal tract and lungs as a result of cosmetic
and medical applications. Oral application is a common
non-invasive method of drug delivery and inhalation
therapy shows promise not only for treatment of respira-
tory diseases, but also for drug delivery to the systemic cir-
culation [5,6]. With the rapid development of
nanotechnology, the use of nanoparticles as drug carriers
or diagnostic tools has moved within reach [7].
In vitro studies on explants, isolated human cells or cell
lines offer a powerful tool for studying substance effects
directly on human biology without using animal studies
or human volunteers. Traditionally, these in vitro experi-
ments have been performed with ex vivo studies of isolated
cells from extracted organs or biopsies under submerged
conditions, where the reactive agent to be investigated is
added to the culture medium, which completely covers
the cells [8,9]. For primary contact organs such as the
lung, the skin, or the eye, this represents an unrealistic way
of exposure, since the in vivo exposure occurs at the air-liq-
uid interface and not under fully immersed (submerged)
conditions. Furthermore, submerged exposures may lead
to interactions between the cell culture medium and the
nanoparticles and to agglomeration of nanoparticles in
the medium, which could affect the particle-induced bio-
logical response. Another disadvantage of submerged cell
exposure to nanoparticles is that the motion of nanopar-
ticles in liquids is mainly driven by random motion (dif-
fusion) and not by directed sedimentation onto the cells
as for larger particles [10,11]. Consequently, under sub-
merged conditions a substantial fraction of the nanoparti-
cles will either remain in the liquid or be lost to the lateral
walls of the cell culture vessel, which alters the dose of
nanoparticles interacting with the cells [11,12]. Direct
exposure of the cells at the air-liquid interface has the
advantage of minimizing these adverse effects, enhancing
the pharmacological and/or toxicological insight gained
from these in vitro experiments.
Several in vitro systems for cell exposure at the air-liquid
interface have been described in the literature, however
most of them were designed for exposure to dry sub-
stances such as cigarette smoke, freshly generated soot
particles or medical and occupational (nano-)powders
[13-17]. For liquid substances, other exposure systems are
required. One of the few approaches reported in the liter-
ature uses a jet nebulizer for droplet formation combined
with an Andersen cascade impactor for inertial droplet
deposition on the cells, which are seeded on the impactor
stages [18]. This system was intended to study the charac-
teristics of aerosol delivery, stability, delivery efficiency,
and expression efficacy of gene products for optimized
inhalation gene therapy. The RHINOCON system was
designed to use commercially available pump-spray units
to spray liquid pharmaceutical formulations directly onto
human pulmonary cells, for efficacy and toxicity testing
[19]. The spray is released into an air flow directed at the
cells onto which the spray droplets are deposited due to
impaction. Similarly, Blank and coworkers [20] used a
spray technique to deposit 1 μm polystyrene particles
onto a human epithelial-like cell line (A549). All of these
systems use impaction as the droplet deposition mecha-
nism, which is likely to induce cellular stress due to the
high flow rates and high speed collisions of the particles
with the cells, and none of these devices provides direct
measurements of the cell deposited substance dose.
In this study, a new exposure system (ALICE) is presented
and validated, for dose-controlled delivery of nanoparti-
cles in liquids or solutions to cell systems cultured at the
air-liquid interface. The uniformity, efficiency, repeatabil-
ity and accuracy of the exposure method is determined
with various solutions and nanoparticle suspensions and
its applicability to toxicological and pharmacological
studies is verified by examining the response of a widely
used human epithelial-like cell line (A549) after exposure
to dilute salt solutions and zinc oxide nanoparticles.
Materials and methods
The air-liquid interface cell exposure system (ALICE)
Principle of operation
The ALICE utilizes cloud settling, in combination with
single particle sedimentation, as the droplet deposition
mechanism. Cloud settling (sometimes also referred to as
bulk motion of aerosol) occurs when the droplet concentra-
tion is sufficiently high (dense cloud) to provide a large
enough flow resistance to cause the air to go around,
rather than through, the cloud of droplets. In this case, the
entire cloud moves as an entity, at a speed significantly
higher than the speed of an individual particle in the air,
since only the outer rim of the cloud experiences drag
forces, while the interior droplets experience no drag.Page 2 of 17
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cally depicted in Figure 1. During phase 1 (Figure 1a), a
dense cloud enters an exposure chamber entrained in an
air flow near the top of the chamber. While the cloud set-
tles rapidly to the bottom of the chamber (where the cells
are located), the droplet-depleted air flow exits the cham-
ber through the opposite side of the chamber. Near the
bottom of the chamber the falling cloud gets diverted to
all sides and forms an almost symmetric pattern of vorti-
ces (Figure 1b), which provides gentle, but sufficient, mix-
ing to establish a spatially uniform cloud layer near the
bottom of the chamber. With the continuous supply of
cloud droplets, the chamber fills from the bottom up with
the most dense cloud layer near the bottom (represented
by the darker shading near the bottom of Figure 1b) and
the lowest droplet concentration near the top (bright
background). During the third phase (Figure 1c), the
cloud (and air) flow is stopped and the droplets settle to
the ground due to single particle settling. Of course parti-
cle settling is also active during phase 1 and 2, but its effect
on cloud depletion is outweighed by the inflowing new
cloud. Since the least dense part of the cloud is in the
upper part of the chamber, extracting the air flow from
this part of the chamber during phase 1 and 2 will not
deplete the amount of droplets in the chamber very much.
The critical design aspects are: i) The cloud has to be dense
enough for rapid "fall-out" so that most of the cloud
remains in the chamber, ii) the air flow introducing the
cloud into the chamber has to be chosen such that the fall-
ing cloud encounters the bottom of the chamber near its
center (uniform distribution of the cloud) and the drop-
lets have to be large enough for rapid single particle sedi-
mentation to the ground. Since vibrating membrane
nebulizers are characterized by high mass output and
large particle diameter, this type of nebulizer is ideal for
the ALICE.
The cloud settling speed can be calculated according to [21]
where Vc, mc and dc are the speed, droplet mass concentra-
tion and diameter (characteristic dimension) of the cloud,
respectively, air is the density of air, CD is the drag coeffi-
cient (depends on particle Reynolds number) and g is the
gravitational acceleration (9.81 m/s2). For an individual
particle, the gravitational settling speed is given by [21]
where Vp, p, dp and Cp are the speed, density, diameter and
slip correction factor of the particle, respectively, and  is
the dynamic viscosity of air.
General setup
The ALICE consists of four main components: 1) a droplet
generator (nebulizer), which provides the dense cloud of
droplets, 2) an exposure chamber, where the droplets
deposit onto the cells located at the bottom of the cham-
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Principle of operation of the air-liquid interface cell exposure system (ALICE)Figure 1
Principle of operation of the air-liquid interface cell exposure system (ALICE). Three phases can be distinguished: 
During phase 1, a dense cloud embedded in an air flow is introduced into the empty chamber (panel a). During phase 2, the 
continuously supplied cloud forms a vortex near the bottom of the chamber and fills the chamber from bottom to top, while 
depleted air is extracted from the top part of the chamber (panel b). During phase 3, the flow and hence the influx of the cloud 
is stopped and the cloud -filled chamber is gradually depleted due to single particle settling (panel c).Page 3 of 17
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vides temperature and humidity conditions suitable for
cell cultivation and 4) a quartz crystal microbalance (QCM)
for real-time dose measurement (Figure 2). As seen in Fig-
ure 2, the droplets are generated by a nebulizer and trans-
ported by a humidified air flow into the exposure
chamber.
Incubation chamber and air flow system
As seen in Figure 2, the ALICE system is operated with a
closed loop flow system at a flow rate of 5 liter/min using
an air pump and a flow meter. This flow rate was chosen
as it transports the falling cloud to the center of the cham-
ber, which is important for uniform spatial distribution of
the aerosol in the chamber, as discussed below. The opti-
mum cell culture conditions (T = 37°C, RH = 80-95%) are
maintained by humidification of the air flow (sample air
bubbles through 37°C water reservoir) prior to entering
the nebulizer, and also by placing the nebulizer and the
exposure chamber in an incubation chamber (polycar-
bonate, Makrolon™), which is thermally stabilized at
37°C using an RH/T-sensor (Model 177-H1, Testo, Ger-
many) and a heating plate (PZ 230, Harry Gestigkeit
GmbH, Germany) placed underneath the incubation
chamber. The air flow exits the chamber through the
opposite side of the entry port and is recirculated through
a particle filter and a cold trap, where the former protects
the pump and the latter avoids condensation of the water
vapor in the "cold" parts of the tubing outside the incuba-
tion chamber.
Nebulizer (eFlow technology)
The liquid substance to be investigated is nebulized by a
vibrating membrane generator (investigational eFlow,
Pari Pharma GmbH, Germany), which was customized
for the ALICE as described below [22,23]. This type of gen-
erator technology (TouchSpray™) utilizes a perforated,
piezoelectrically-driven vibrating membrane to induce
acoustic pressure waves, which periodically press small
amounts of liquid through the tapered holes of a mem-
brane. In the current study, the thin stainless steel mem-
brane is perforated by about 3000 holes and vibrates at a
frequency of 117 kHz. The nebulizer used in the current
study has a reservoir chamber for spraying 0.5 to 5 mL of
liquid, high liquid volume or mass output (up to 1.0 mL
of liquid per min), a small residual amount of liquid in
the reservoir (0.05-0.1 mL) and a narrow droplet size dis-
tribution (geometric standard deviation: 1.50-1.65) and it
is characterized by a highly reproducible performance.
The investigational eFlow switches off automatically after
the liquid reservoir has been emptied. The nebulizer
membrane was regularly cleaned by 5 min sonification in
water. For zinc oxide (ZnO) and carbon black suspen-
sions, the cleaning procedure was performed after every
discharge in order to avoid partial clogging of the mem-
brane pores which would result in reduced output effi-
ciencies.
Experimental setup of the air-liquid interface exposure system (ALICE)Figu e 2
Experimental setup of the air-liquid interface exposure system (ALICE).
Cold trapPage 4 of 17
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applied investigational eFlow used i) a membrane with
larger holes resulting in larger mass output and larger par-
ticles (here: mass median diameter MMD = 4.4-5.4 μm),
which is important for rapid cloud settling and short
droplet sedimentation time and ii) an aerosol chamber
with an air inlet at the side and an aerosol outlet through
the front (directly opposite of the membrane), which can
be directly connected to the exposure chamber. With this
setup, the distance between the vibrating membrane and
the exposure chamber was 5 cm, the inner diameter of the
connector to the chamber was 1.9 cm and the flow rate
was 5 liter/min.
Exposure chamber
Exposure of the cells with the substance under investiga-
tion occurs in the exposure chamber, designed to hold up
to two standard transwell plates (1 cm away from the
walls of the chamber) containing cells cultured at the air-
liquid interface. Immediately after exposure to the neb-
ulized substance, the transwell plates can be easily
removed (within a few seconds) from the chamber via a
drawer for further analytical processing or post-incuba-
tion of the cells.
The exposure chamber is a 12 liter box (bottom plate: 20
× 20 cm2; height: 30 cm) made of polycarbonate (Makro-
lon™) with plates held in place by an aluminum frame.
Makrolon is durable enough for repeated sterilization
with alcohol and its transparent nature allows visual
inspection of the motion of the cloud and the extent to
which the chamber is filled with droplets (denser clouds
appear more opaque). The highly concentrated cloud
enters through the left side wall (in the center, 20 cm
above the bottom) and gravitates swiftly to the ground
(within ~1 s) due to cloud settling. The bulk motion of the
cloud, which resembles "white smoke", can easily be
observed with the naked eye. Using optical confirmation,
the flow rate of 5 liter/min was chosen such that the fall-
ing cloud column reaches the bottom plate near its center
in order to facilitate formation of an almost symmetric
pattern of upwards vortices for uniform cloud mixing.
Quartz crystal microbalance (QCM)
Mass deposition onto the cells was measured with a
quartz crystal microbalance (QCM 200/25, Stanford
Research Systems, Sunnyvale, CA, USA) placed on the
ground plate of the exposure chamber. The QCM is typi-
cally placed in one of the corners of the chamber, but the
exact location is irrelevant, since the droplet deposition is
spatially uniform, as is shown below. Mounting the QCM
on a movable sledge allows for fast (within one second)
and easy removal and insertion of the QCM, with mini-
mum perturbation inside the exposure chamber.
The QCM determines the particle mass deposited onto a
vibrating piezoelectric quartz crystal from the linear
decrease in the resonance frequency of the crystal with
increasing deposited mass. The QCM 200/25 uses a circu-
lar, AT-cut, α-quartz crystal with a resonance frequency of
5 MHz and operates at a sampling rate of 1 Hz. From the
exposed crystal surface area, of 1.37 cm2, only the inner
0.4 cm2 is active (experiences a displacement within the
plane of the crystal). The change in mass per unit area
(Δm) is related to the observed change in oscillation fre-
quency (Δf) of the crystal by the Sauerbrey equation
where Cf = 56.6 Hz cm2/μg (at room temperature) for a 5
MHz, AT-cut, α-quartz crystal. The Sauerbrey equation is
valid only for uniform, rigid, thin films, where thin
implies that Δf < 105 Hz (2% of original resonance fre-
quency) or Δm < 1770 μg/cm2 (equation 3). The sensitiv-
ity constant Cf is a fundamental property of the crystal, so
that the QCM does not require calibration [24].
For liquid films the Sauerbrey equation is not valid, since
in this case the observed frequency change not only
depends on the deposited mass of the film, but also on the
viscosity and density of the liquid, as well as other factors
such as the layer thickness, adsorption of material to the
crystal and formation of sublayers within the film [24].
Hence, no simple linear dependence of frequency shift on
deposited mass can be expected for liquid films, but an
increase in Δf is generally related to an increase in depos-
ited mass, if the frequency shift remains below the asymp-
totic value for an infinitely thick layer of a given liquid.
For water at 20°C, the asymptotic frequency shift is 715
Hz [25]. Hence, the QCM can be used as a real-time indi-
cator for the deposition of droplets, but for accurate meas-
urement of the cell deposited active substance
(nanoparticles, solute), the liquid film has to be dried
(here with dry air flow) and then interpreted using equa-
tion 3.
According to the manufacturer, surface-specific masses
below 1 ng/cm2 (Δf < 0.05 Hz) can be detected. Although
this is close to the observed zero point stability of <0.1 Hz,
a more conservative lower detection limit of 18 ng/cm2
was adopted (Δf = 1 Hz), since small temperature drifts
can not be ruled out. The detection limit of18 ng/cm2 cor-
responds to 25 ng of mass deposited on the exposed part
of the QCM crystal (1.37 cm2). For ZnO nanoparticles
used here, this corresponds to a uniform layer thickness of
0.03 nm or about 0.1 monolayers (density = 5.6 g/cm3).
Substances used for ALICE characterization
Solutions and nanoparticle suspensions can be used in
the ALICE. The characterization of the ALICE was per-
Δ Δm f C f= − . (3)Page 5 of 17
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nium sulfate ((NH4)2SO4) and citrate solutions and with
aqueous suspensions of gold (Au), ZnO and carbon black
nanoparticles. The aqueous suspension of 15 nm Au nan-
oparticles, which was stabilized by 10 mM citrate (500 μg/
mL), was purchased from British Biocell (EM.GC15, Batch
7894, British Biocell International, Plano GmbH, Wetzlar,
Germany). The nominal particle concentration was 1.4 ×
1012 particles/mL (mass concentration: 40 μg/mL = 40
ppm with a gold density of 19 g/cm3). Additionally, a 10
fold enriched Au suspension was prepared by centrifuga-
tion of the suspension at 18,626 RCF (relative centrifugal
force) for 20 min and by removing 90% of the (particle-
free) supernatant. The ZnO and carbon black nanoparticle
suspensions were prepared in our lab from commercially
available powders (ZnO: AlfaAesar, Ward Hill, MA, USA
Id# 43141; primary diameter: 24-71 nm (manufacturer
information); BET surface area: 13 m2/g, agglomerated.
Carbon Black: Printex 90, Degussa (now Evonik), Ger-
many; primary diameter: 14 nm; agglomerated). The ZnO
and carbon black suspensions were prepared, as well as
vortexed and sonicated twice for 1 min intermittently
immediately prior to spraying the suspension with the
nebulizer.
Characterization of uniformity and efficiency of droplet 
deposition in the ALICE
The uniformity of the droplet deposition in the exposure
chamber was determined by placing 12 pieces of alumi-
num foil (3 × 3 cm) on the ground plate of the exposure
chamber. Before and after exposure of the foils to the neb-
ulized substances in the ALICE, their dry weight was deter-
mined by a gravimetric microbalance (Model r160p,
Sartorius, Germany, accuracy ≤± 0.02 mg) and the depos-
ited (dry) mass was determined from the change in foil
mass. Adding all foil deposited salt masses, and scaling to
the total area of the exposure chamber, yielded the total
deposited salt (or nanoparticle) mass. The deposition effi-
ciency was determined from the ratio of the total depos-
ited (dry) mass and the mass filled into the nebulizer
reservoir. The spatial uniformity of the deposition was
determined from masses deposited onto the 12 foils. A
qualitative representation of the spatial uniformity was
obtained by transmission electron microscopy (TEM,
CM12, FEI Co. Philips Electron Optics, Zürich, Switzer-
land) using a primary magnification of 3400× and
25,000× for Au and ZnO nanoparticles collected on TEM
grids in the ALICE.
Time-resolved mass deposition was obtained for NaCl
and (NH4)2SO4 solutions as well as for Au and ZnO sus-
pensions by placing the QCM on the ground plate of the
exposure chamber during an ALICE run.
For Au nanoparticles, the deposited mass was not only
determined indirectly with the QCM (using the mass ratio
of citrate and Au), but directly with gamma spectroscopy
performed by the Helmholtz Zentrum Berlin in Berlin,
Germany. The latter involved neutron activation of Au-
197 into Au-198 (neutron flux was about 6 × 1012 cm-2s-1
for 1 hour) and subsequent determination of the Au mass
on the aluminum foils from the intensity of the 412 keV
gamma line of Au-198, relative to a known standard. As
the obtained Au mass from QCM and gamma spectros-
copy agreed within experimental uncertainties, both
methods are considered equivalent.
Cell exposure experiments
Preparation of salt solutions and nanoparticle suspensions
For the ALICE experiments, ZnO suspension of 0.3, 1.5
and 7.5 mg ZnO/mL sterile H2O (Braun, Melsungen) were
prepared immediately prior to use from three stock sus-
pensions of 1 mg/ml, 2 mg/ml and 10 mg/ml, respec-
tively. The stock suspensions were produced, vortexed and
sonicated twice for 1 min intermittently and then diluted
with water to obtain 1 ml of ZnO suspension for nebuli-
zation. For control purposes, cells were also exposed to
dilute (10 mM) aqueous citrate (stabilization agent in Au
suspension) or NaCl solutions, which were also prepared
immediately prior to nebulization.
For ZnO exposure under submerged conditions, the
desired amount of ZnO was incorporated directly into the
cell culture medium by adding the appropriate volume of
a 1 mg ZnO/mL H2O stock suspension. Within 30 min
ZnO agglomerates of about 900 nm (mobility diameter)
had formed in the cell culture medium as determined by
dynamic light scattering measurements (HPPS 5001, Mal-
vern Instruments Ltd, Worcestershire, UK). As agglomer-
ates of this size are known to efficiently deposit (near
100%) due to sedimentation [11], the cell deposited par-
ticle mass under submerged conditions was inferred, from
the amount of ZnO mixed into the cell culture medium.
Cell handling for ALICE experiments
All exposure experiments were performed with a human
epithelial-like cell line (A549) from a lung adenocarci-
noma (obtained from ATTC, Manassas, VA, USA) repre-
senting the alveolar type II phenotype [26]. Cells were
seeded into cell culture inserts (BD Falcon, transparent
PET membrane, effective growth area 4.2 cm2, 1 μm pore
size, 1.6 × 106 pores/cm2) with about 0.12 × 106 cells per
cm2 and cultivated under submerged conditions with
DMEM/F12/L-Glut/15 mM HEPES buffer (Invitrogen,
Germany) as culture medium, containing 100 Unit/mL
penicillin, 100 μg/mL streptomycin and 10% fetal calf
serum (FCS). The inserts were placed in BD Falcon™ 6-
well tissue culture plates with 2 mL medium in the upper
(insert) and 3 mL in the lower compartment. After 7 days
of growth under submerged conditions at 37°, the cells
had formed a confluent monolayer (0.3 × 106 per cm2).
Subsequently, the cells were transferred to the air-liquidPage 6 of 17
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the cells and incubating them for another 18 h in the cell
incubator. Following this procedure, it was shown that
A549 cells closely resemble in vivo conditions by forming
tight junctions and secreting a thin surfactant layer at the
apical side of the cells [20].
Then the medium in the lower chamber was replaced with
3 mL serum-free culture medium and the cells were placed
in the exposure chamber of the ALICE system for exposure
to ZnO nanoparticles (or salt solutions) as described
above. After 10 min in the ALICE, the cells were removed
and incubated for 3 h in the cell incubator. Immediately
after the post-incubation period, the cells were washed
with PBS and directly lysed on the insert membrane by
adding 350 μl of a cell lysis buffer, suitable for isolation of
total RNA (Qiagen) (further details see RT-PCR section),
or 2 mL WST-1 containing medium was added to the
upper compartment (insert) to measure cell viability (fur-
ther details are given below).
Cell handling under submerged exposure conditions
Adopting one of the most frequently used cell handling
procedures for toxicological experiments [27,28], the
A549 cells were seeded at 0.25 × 106/cm2 in 24-well plates
(growth area 2 cm2) and incubated for 16 h in DMEM cell
culture medium with FCS (see above) resulting in a cell
density of approximately 0.4 × 106/cm2. For ZnO expo-
sure, the culture medium was replaced with 1 mL serum-
free medium into which various amounts of ZnO particles
(0.7, 2.5, 5 μg/cm2) were given by adding the appropriate
volume of a 1 mg ZnO/mL H2O stock suspension. Subse-
quently, the A549 cells were incubated for 3 h. Biological
parameters are reported relative to control conditions
(incubated cell cultures without ZnO).
qRT-PCR analysis for analysis of IL-8 and HO-1 mRNA expression
Gene expression at the mRNA level of interleukin-8 (IL-8)
and hemeoxygenase-1 (HO-1) was measured, 3 h after
exposure, by quantitative reverse transcription polymer-
ase chain reaction (qRT-PCR). The exposed cells were
lysed and total RNA was purified using the Qiagen RNeasy
Mini Kit (Qiagen GmbH, Hilden, Germany) according to
the manufacturer's instructions. First-strand cDNAs were
synthesized by reverse transcription from 0.5 μg total
DNase I-treated RNA with a random nonamer primer
(Metabion, Martinsried, Germany) and Superscript II
reverse transcriptase (Invitrogen, Karlsruhe, Germany).
For PCR amplification, the cDNA was mixed with the spe-
cific 5' and 3'primers and transcript levels were quantified
using Absolute QPCR SYBR Green Mix plus ROX kit
(ABgene, Hamburg, Germany) with the ABI Prism 7000
Sequence Detection System (Applied Biosystems, Foster
City, CA, USA). The housekeeping gene GAPDH was used
as internal reference to normalize the mRNA levels of the
genes being studied, and IL-8 and HO-1 induction is
reported after normalization to control conditions. The
following primers were used: IL-8 5'primer: IL-8 5'primer:
5'-ATG ACT TCC AAG CTG GCC GTG GCT-3'; IL-8
3'primer: 5'-TCT CAG CCC TCT TCA AAA ACT TCT C-3';
HO-1 5'primer: 5'-AAG ATT GCC CAG AAA GCC CTG
GAC-3'; HO-1 3'primer: 5'-AAC TGT CGC CAC CAG AAA
GCT GAG-3'; GAPDH 5'primer: 5'-CCA TGA GAA GTA
TGA CAA CAG CC-3'; GAPDH 3'primer: 5'-TGG CAG GTT
TTT CTA GAC GG- 3'.
Viability assay
Cell viability was measured with the cell proliferation rea-
gent WST-1 (Roche Applied Sciences, Germany). The
ready-to-use WST-1 reagent was mixed with cell culture
medium (100 μl/mL) and was added to the apical side of
the cells for both air-liquid interface and submerged cul-
ture conditions. After 30 min incubation at 37°C, the
light absorbance at 450 nm was measured.
Results
Performance of the nebulizer
The mean volume (or mass) output of the nebulizer was
determined by measuring the nebulization time for a
known amount of liquid, which was accomplished by
observing the clearly visible dense cloud of droplets gen-
erated by the nebulizer. For nebulization of 1 mL of salt
solution or nanoparticle suspension, the nebulizer
needed between 90 and 150 s and the corresponding vol-
ume (mass) production rates were between 0.40 and 0.67
mL/min (or 0.40 and 0.67 g/min). The small amount of
residual liquid in the nebulizer was disregarded (5-10%
for 1 ml of liquid filled into the reservoir volume; meas-
ured by gravimetric analysis of the nebulizer before and
after discharge). Consequently, the aerosol (droplet) mass
concentration was approximately 80-130 g/m3 for a sam-
ple flow rate of 5 liter/min.
For consecutive nebulizer runs with 1 mL of 1% NaCl
solution and various nanoparticle suspensions, the neb-
ulization times were constant within ± 10 s, which means
that the short term repeatability was better than 7%. How-
ever, a gradual increase in nebulization time was observed
with increasing use of the membrane. For further details
on the characteristics of the eFlow nebulizer, please refer
to [22,23].
Aerosol dynamics during ALICE experiments
The droplet deposition on the cells during ALICE expo-
sure was monitored by placing the QCM in the exposure
chamber next to the transwell plates containing the cells.
As mentioned previously, for liquid films the quantitative
interpretation of the change in resonance frequency ( f) of
the QCM is altered by various aspects (such as the viscoe-
lastic properties of the film), but the QCM can be used asPage 7 of 17
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quency shift for an (infinitely) thick water layer. By dip-
ping the QCM crystal into water the asymptotic value of
715 Hz was confirmed, as recommended by the manufac-
turer.
The response of the QCM during a typical ALICE exposure
is depicted in Figure 3. Droplet deposition (increase of -
Δf) starts almost immediately (within 2 s) after the neb-
ulizer is turned on (t = 0). At 110 s, the nebulizer is com-
pletely discharged (1 mL of 6% (NH4)2SO4 solution was
sprayed) and the air flow is stopped. At 300 s, 95% of the
final -Δf value (630 Hz) is reached (end of droplet depo-
sition). During a typical ALICE experiment, the cells were
removed at 600 s, but data presented in Figure 3 were
obtained without cells. No change in -Δf is observed after
about 900 s and this value remains constant for hours, if
the system is not disturbed (data not shown). At 900 s, the
QCM deposit is dried by passing dry filtered air (5 liter/
min) into the exposure chamber. The deposit has com-
pletely dried at about 1500 s as indicated by the resistance
(R) approaching 0 Ω, which is a measure for the dissipa-
tion of vibrational energy of the quartz crystal due to vis-
coelastic dampening. At R = 0 Ω, no viscoelastic effects are
present, and therefore the deposit is dry. The dry salt mass
of 72.4 μg/cm2 can then be obtained from -Δf = 4100 Hz
using equation 3. Use of the QCM as real-time indicator
for droplet mass deposition is not feasible, if the amount
of liquid sprayed exceeds 1 mL, due to the vicinity of -Δf
to its asymptotic value (715 Hz).
The data in Figure 3a can be used to identify the lengths of
the three phases of the ALICE operation described above
(Figure 1). The dense cloud of droplets reaches the bot-
tom of the chamber within 2 s after the nebulizer is acti-
vated (end of phase 1). During phase 2 the chamber is
gradually filled with droplets until the nebulizer is com-
pletely discharged at 110 s (end of phase 2). Phase 3, grad-
ual depletion of the chamber due to single particle
settling, is finished after another 190 s.
Hence, the timing of the ALICE experiments can be opti-
mized as follows: The cells and the QCM can be removed
from the ALICE after 300 s (5 min) and drying of the
QCM deposit outside of the exposure chamber can be
accomplished with dry air within a few minutes. There-
fore, if the QCM does not need to be cleaned (or if a sec-
ond clean quartz crystal is available) an entire ALICE run
can be performed within ~10 min.
The relevance of cloud settling for the ALICE becomes evi-
dent, if the cloud settling and the single particle settling
speed are compared. According to Figure 3, the fall time of
the cloud to the bottom of the chamber is between 1 and
2 s (onset of -Δf signal), although a more precise determi-
nation is not possible due to the sampling frequency of 1
Hz. For a fall distance of 20 cm (distance of inlet port
above the ground), this corresponds to 10-20 cm/s. For a
droplet concentration of 80-130 g/m3 and a cloud diame-
ter of 1.9 cm (inner diameter of inlet tube), the theoreti-
cally expected cloud settling speed is between 13-17 cm/s
according to equation 1 (CD = 1, [21]), which is in good
agreement with the empirical value. Since the single parti-
cle settling speed is only 0.077 cm/s (= 4.6 cm/min; 5 μm
droplet diameter), the significance of cloud settling for
rapid transport of the nebulized substance to the cells is
evident. Furthermore, the fact that droplet deposition has
ceased almost completely 3 min after the nebulizer has
been discharged, suggests that most of the cloud mass
resides in the lower half of the exposure chamber, since 5
μm droplets settle about 15 cm in 3 min. This indicates
that cloud and single particle settling explain the QCM
signal observed in Figure 3a.
Performance of the QCM for dry deposits
As mentioned, the dry nanoparticle/solute mass depos-
ited on the cells can be determined from the dried deposit
on the QCM. This was verified by comparing the QCM
with gravimetric data for dry (NH4)2SO4 and NaCl, as well
as carbon black and ZnO nanoparticles, sprayed in the
ALICE, as described above. As seen in Figure 4, both tech-
niques showed excellent linear correlation (R2 = 0.96) and
agreement within 7.3% (slope = 1.073). No saturation of
the QCM was observed up to 160 μg/cm2. This is consist-
ent with the manufacturers provided upper limit of the
linear response range of 1770 μg/cm2. Measurements
below 3 μg/cm2 were impossible due to the detection
limit of the gravimetric method.
This confirms the validity of the Sauerbrey equation
(equation 3) and shows that the QCM can be used for
accurate mass measurements in the ALICE. The validity of
the Sauerbrey equation also implies that the prerequisite
of the Sauerbrey are met, namely the formation of a uni-
form, rigid and thin layer on the quartz crystal after expo-
sure in the ALICE.
Spatial homogeneity and liquid film thickness in the ALICE
The good agreement between the QCM and the gravimet-
ric mass already suggests that the droplet deposition is
spatially homogeneous on the sensitive part of the quartz
crystal (0.4 cm2), since this is a pre-requisite for the valid-
ity of the Sauerbrey equation. This important issue was
investigated more rigorously by distributing 12 rectangu-
lar pieces of aluminum foils (3 × 3 cm2) over the exposure
chamber (see insert in Figure 5), while spraying 1 mL of
10% NaCl solution into the exposure chamber following
the standard ALICE procedure described above. On aver-
age, 1.45 mg NaCl was deposited per foil, which corre-
sponds to 162 μg/cm2, and the gravimetric analysis of thePage 8 of 17
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Response of the quartz crystal microbalance (QCM) during a typical ALICE exposureFigure 3
Response of the quartz crystal microbalance (QCM) during a typical ALICE exposure. a) Within 2 s of the neb-
ulizer being turned on (t = 0) - f increases due to droplet deposition on the quartz crystal. At 110 s, the nebulizer is completely 
discharged (here: 1 mL of 6% (NH4)2SO4 solution) and the air flow is stopped. Subsequently, single particle sedimentation 
depletes the stagnant cloud and at 300 s, 95% of the final -Δf value (630 Hz) is reached (end of droplet deposition), which is still 
well below 715 Hz, the saturation value of the QCM for an infinitely thick water layer. During typical ALICE experiments, the 
cells were removed at 600 s (here no cells were in the ALICE). b) At 900 s dry filtered air is introduced in the exposure cham-
ber, which dries the liquid film on the QCM. At 1500 s, the QCM deposit has completely dried, as indicated by the resistance 
(R) approaching 0 Ω. The dry salt mass of 72.4 μg/cm2 can then be obtained from -Δf = 4100 Hz using equation 3. For opti-
mized timing (~10 min per exposure run) the cells could be removed from the ALICE after 300 s (5 min) and the QCM deposit 
can be dried more efficiently (within a few minutes) by removing the QCM from the exposure chamber and drying it with dry 
air.
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Particle and Fibre Toxicology 2009, 6:32 http://www.particleandfibretoxicology.com/content/6/1/32dried foils (n = 4) revealed that the observed spatial vari-
ability was 1.6%. Since this value is consistent with the
estimated measurement accuracy (1.6%), no statistically
significant spatial uniformity was found in the exposure
chamber.
The high degree of homogeneity was also confirmed for
Au and ZnO nanoparticles by placing a TEM grid in the
ALICE. Since similar results were obtained for both nano-
particle types, only the ZnO data are shown here. As seen
from Figure 6, the ZnO coverage increases with the ZnO
concentration in the suspension and, although larger
agglomerates are starting to appear for the higher concen-
tration, their fractional contribution is still small. This
indicates that no substantial particle agglomeration has
occurred during the ALICE experiment, even for the high-
est ZnO concentration. In contrast, ZnO agglomeration is
not negligible during submerged exposure, since agglom-
eration is enhanced in the presence of cell culture medium
[29] as seen by the formation of large agglomerates (900
nm) within 30 min as determined from dynamic light
scattering measurements described above.
It is also evident from Figure 6 that the deposition pattern
is uniform for both concentrations and no micron-sized
patches or "hot spots" of nanoparticles are present as
might be expected after deposition of individual micron-
sized droplets (MMD = 4.4-5.4 μm). This can be rational-
ized by considering the thickness of the liquid layer on the
grids (cells) after ALICE exposure. From the deposition
efficiency evaluation of the droplets in the chamber (0.57
± 0.07 as determined below) and the area of the ground
plate of the exposure chamber (400 cm2), we find that a
continuous 14 μm liquid layer is formed in the ALICE for
1 mL of nebulized suspension. For 5 μm (MMD) droplets,
this means that on average 4.2 droplets are falling on each
location of the exposure chamber. The theoretical mini-
mum thickness of a continuous layer (perfectly uniform
deposition of drops with 1 drop per location) is 3.3 μm
(=2/3 MMD), which corresponds to 0.24 mL of sprayed
liquid. However, if a continuous layer is desired, spraying
at least 0.5 mL is recommended in order to compensate
for small variations in the deposition pattern.
Efficiency and repeatability of droplet deposition
Another important characteristic of the ALICE is the dep-
osition efficiency of the nebulized material on the bottom
of the exposure chamber or even more importantly on the
cells. Since the deposition efficiency on the cells depends
on cell coverage and hence on the type of transwell plates
used, the deposition efficiency was initially investigated in
the exposure chamber, which is defined as the ratio of sol-
ute (or nanoparticles) mass deposited on the bottom
plate and solute/nanoparticle mass filled into the neb-
ulizer. As seen from Figure 7, the mean and standard devi-
ation of the deposition efficiency was 0.57 ± 0.07,
independent of the type of solution (NaCl, (NH4)2SO4)
or nanoparticle suspension (ZnO, Au). Gravimetric anal-
ysis indicated that 5-10% and 15-20% of the liquid
remained in the nebulizer and the exit filter, respectively.
The unaccounted remainder of 10-20% must have been
deposited in the connecting tubing and the side/top walls
of the exposure chamber. Since the cell-specific deposi-
tion efficiency depends on the fractional cell coverage of
the exposure chamber (400 cm2), the deposition effi-
ciency on the cells is lower than 0.57. If two standard
plates with 6-, 12- or 24-transwell inserts are placed in the
ALICE, 50.4, 21.6 and 14.4 cm2 of the exposure chamber
are covered with cells resulting in a cell-specific deposi-
tion efficiency of 0.072, 0.031 and 0.021, respectively.
The standard deviation (0.07) of the deposition efficien-
cies (n = 30) represents the repeatability of substance
delivery to the cells in the ALICE (Figure 7). Since the
mean deposition efficiency is 0.57, the repeatability of the
ALICE is 12% (=0.07/0.57) for the solutions and suspen-
sions investigated here.
It is noteworthy that the deposition efficiency is inde-
pendent of the amount of sprayed material as was con-
firmed for 1 mL to 5 mL salt solutions and nanoparticle
suspensions. This indicates that all "loss mechanisms" are
independent of time including the depletion of the sam-
ple flow due to cloud settling.
Comparison of quartz crystal and gravimetric microbalanceFigure 4
Comparison of quartz crystal and gravimetric micro-
balance. Measurement of the mass deposited on the bot-
tom plate of the ALICE by QCM and gravimetric analysis 
after nebulization of 1-5 mL of (NH4)2SO4, NaCl, carbon 
black and ZnO solutions/suspensions with concentrations 
ranging between 2-10% (salts) and 0.1-2% (carbon black and 
ZnO nanoparticles). The (dry) mass per surface area as 
determined by QCM and gravimetry showed excellent line-
arity (R2 = 0.962) and agreement within 7.3% (slope) over the 
investigated range from 3 to 160 μg/cm2.
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Effect of ALICE exposure on cell viability
Potential adverse effects of cell handling on cell viability
(WST-1 test) during ALICE experiments were investigated
with A549 lung epithelial cells. Although the viability of
the cells was slightly impaired (87 ± 2% relative to sub-
merged cells; Figure 8) after exposure to 1 mL of 10 mM
aqueous NaCl (0.9 μg/cm2 NaCl) and 10 mM tri-sodium
citrate dihydrate solution (4.4 μg/cm2 citrate), there was
no significant difference between exposed and non-
exposed cells. The somewhat reduced viability was likely
due to the 18 h adaptation of the cells to the air-liquid
interface conditions (prior to exposure) and not due to
the ALICE exposure procedure. It is noteworthy that slight
reductions of cell viability after transfer of submerged cells
to the air-liquid interface were also reported by other
investigators ([19,30,31]). Consequently, neither cell
handling in the ALICE nor exposure of the cells to salt
solutions impaired cell viability.
Comparison of cellular response under submerged and air-liquid 
interface conditions after ZnO exposure
As an application of the ALICE system, A549 cells were
exposed to various doses of ZnO nanoparticles and the
mRNA expression of the pro-inflammatory cytokine IL-8
and the oxidative stress marker HO-1 were investigated.
Cell viability (WST-1) was not impaired for any of the par-
ticle concentrations used here (data not shown). The ratio
of mRNA levels from the air-liquid interface and sub-
merged conditions in the absence of ZnO was 1.9 and 1.4
for IL-8 and HO-1, respectively. This reflects the effect of
transferring the cells to the air-liquid interface conditions.
Furthermore, since there was no significant difference
between non-exposed and 10 mM citrate-exposed cells at
the air-liquid interface (data not shown), both non-
exposed and 10 mM citrate-exposed cells can be used as
negative control for ALICE experiments.
ALICE experiments were performed with ZnO nanoparti-
cle doses of 0.3, 1.9 and 8.5 ZnO μg/cm2 (n ≥ 3). For ref-
erence, ZnO exposures under submerged conditions were
also conducted at 0.7, 2.5 and 5.0 ZnO μg/cm2 (n ≥ 4). As
discussed above, the ZnO dose was determined from the
amount of ZnO nanoparticles added to the culture
medium. As seen in Figure 9, the IL-8 and HO-1 mRNA
expression increased with ZnO dose for both ALICE and
submerged conditions, but none of the responses was sta-
tistically significant below 1.0 μg/cm2. For IL-8, the ALICE
Spatial uniformity of droplet depositionFigure 5
Spatial uniformity of droplet deposition. Measurement of (dry) NaCl mass (proportional to droplet mass) deposited on 
12 aluminum foils (3 × 3 cm2) placed in the exposure chamber (see insert) after nebulization of 1 mL of a 10% NaCl solution in 
the ALICE. Droplets enter the chamber from the left and the droplet depleted air exits through the right hand side. The data 
are presented as relative difference from the mean deposited mass on each foil (n = 4) and the variability about the mean. The 
average of these mean values is 0% (per definition) and the variability of the mean values (spatial uniformity) is 1.6% (dashed 
lines). Since this is identical to the estimated measurement uncertainty, the data indicate uniform particle deposition across the 
exposure chamber.
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Particle and Fibre Toxicology 2009, 6:32 http://www.particleandfibretoxicology.com/content/6/1/32and the submerged data agreed within experimental
uncertainties except for the highest dose, where a higher
response was observed under submerged conditions (Fig-
ure 9a). In contrast, HO-1 was clearly more induced in the
ALICE except for the lowest concentration. Hence, the cel-
lular dose-response for IL-8 and HO-1 was different under
air-liquid interface and submerged conditions.
Discussion
Due to the well-known shortcomings of submerged cell
exposure systems for pharmaco-toxicological studies on
pulmonary epithelial cells (such as uncertain effective
biological dose for nanoparticles and unrealistic exposure
scenario due to missing air-liquid interface and absence of
mucus or lining fluid on respiratory epithelial cells), there
have been several approaches to develop exposure sys-
tems for cells at the air-liquid interface. In the CULTEX
system, particles are deposited from a continuous aerosol
flow by diffusional and gravitational deposition onto cells
[14]. Bitterle and coworkers refined this approach by
establishing a stagnation point flow over the cell layer,
which enhanced the deposition efficiency of 200 nm sub-
micron sized particles from about 0.7% [32] to 2% [13].
Deposition efficiencies of 15-30% were obtained for
charged 50-600 nm particles under the influence of an
alternating electrostatic field [16] or in the EPDExS system
utilizing unipolar electrostatic deposition downstream of
a differential mobility particle sizer [33]. None of these
types of devices was designed for nebulized liquid sub-
stances (micron-sized droplets) and none of them (except
for one Bitterle type system using a QCM for dose meas-
urement [34]) allows for real-time, direct measurement of
the amount of particles deposited onto the cells, but
rather infer the cell deposited dose indirectly from the
product of the measured particle concentration in the air
and the empirically determined deposition efficiency.
TEM micrograph of ZnO nanoparticles deposited in the ALICEFigure 6
TEM micrograph of ZnO nanoparticles deposited in 
the ALICE. Depicted are representative micrographs 
obtained after nebulization of 1 mL of ZnO suspension (pri-
mary diameter 24-71 nm) with two different concentrations, 
a) 0.3 mg/mL and b) 7.5 mg/mL. As expected, the ZnO cov-
erage increases with ZnO concentration and, although larger 
agglomerates are starting to appear for the higher concentra-
tion, their fractional contribution is still small. In both cases 
the deposition pattern is uniform not only on the mm scale 
as shown in Figure 5, but also on the scale of single droplets 
(micron scale). This is consistent with the formation of a 
continuous 14 μm liquid film after nebulization of 1 mL of 
suspension (estimated from deposition efficiency and cham-
ber geometry), which implies that more than 4 droplets 
deposit on each location of the chamber.
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Deposition efficiency of nanoparticles and solutes on the bot-tom of the xposure chamberFigure 7
Deposition efficiency of nanoparticles and solutes on 
the bottom of the exposure chamber. All measure-
ments were performed after nebulization of 1 mL of suspen-
sion/solution with varying nanoparticle/solute mass 
concentration. The symbols represent the mean and stand-
ard deviation (error bars) for up to 12 independent measure-
ments (no error bar for n = 1). The solid and dashed lines 
indicate the mean (0.566) and standard deviation (0.067) of 
the entire data set, respectively. The 68% confidence level 
(SEM) of the mean is 0.012 (n = 30). The detection limit of 
the QCM (12.4 ppm) corresponds to 18 ng/cm2.
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Particle and Fibre Toxicology 2009, 6:32 http://www.particleandfibretoxicology.com/content/6/1/32Previously described methods for deposition of micron-
sized particles or droplets onto cells have relied on inertial
impaction as the deposition mechanism. The use of
impactors or impingers [15,17,18,35] requires high flow
rates for effective particle deposition, which may impair
cell viability [36] and the deposition efficiency is also
strongly dependent on particle size [21]. While the high
flow speed (30 cm/s in the device by [17]) may simulate
in vivo conditions in the respiratory bronchioles after a
sharp inspiration [17], it exceeds typical flow speeds
under normal breathing conditions and is completely
unrealistic for the alveolar regime, where flow velocities
are so small that deposition due to impaction can be dis-
regarded [37]. A second type of cell exposure system for
liquids utilizes high velocity sprays to deposit the liquid
directly onto the cells via inertial impaction [19,20].
High-speed spray-deposition does not occur under in vivo
conditions (except in the mouth after using a medical
spray nebulizer), and both systems may induce cellular
stress due to high speed droplet collisions. Again, none of
the systems above provides information on the cell depos-
ited dose.
The ALICE utilizes a completely different, more "gentle"
technique of particle generation and deposition and it
provides direct dose measurements. As discussed above,
micron-sized droplets (MMD = 4.5-5.4 μm) are generated
at a very high concentration (80-130 g/m3) by a vibrating
membrane nebulizer and are uniformly deposited via
cloud and single particle settling onto cells at the air-liq-
uid interface. It is noteworthy that the cloud settling speed
of 13-17 cm/s is too small for impaction to occur, as evi-
denced by the absence of enhanced droplet deposition
near the center of the chamber, where the cloud speed is
largest (see foils 5 and 8 in Figure 5). While impaction is
a relevant deposition process in the upper respiratory
tract, gravimetric sedimentation simulates the in vivo con-
ditions of supermicron particle deposition in the alveolar
region. The gentle form of particle deposition (compared
to impaction) minimizes mechanical strain and subse-
Effect of cell handling on cell viability during ALICE experi-mentsFigure 8
Effect of cell handling on cell viability during ALICE 
experiments. Cell viability (WST-1 test; 3 h incubation 
after exposure) was measured in immortalized human alveo-
lar epithelial-like cells (A549). "No expo" cells were treated 
identical to ALICE cells except that they were not put into 
the ALICE and instead they remained in the incubator. Cells 
maintained under submerged conditions served as a control 
(100%). Cell viability was slightly impaired for all cases (87 ± 
2%), but there was no statistically significant difference 
between 10 mM NaCl- and citrate-exposed cells and not 
exposed cells. Hence, the slightly reduced cell viability (rela-
tive to submerged conditions) is likely due to culturing the 
cells for about 18 h at the air-liquid interface prior to expo-
sure, but not due to cell handing in the ALICE.
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Cellular dose-response due to ZnO nanoparticle exposure under subm rg d and air-liquid i terface conditionsFigu e 9
Cellular dose-response due to ZnO nanoparticle 
exposure under submerged and air-liquid interface 
conditions. The dose-dependent IL-8 (pro-inflammatory) 
and HO-1 (oxidative stress) mRNA expression in A549 cells 
was measured with qRT-PCR after ZnO exposure in the 
ALICE (3 h post-exposure incubation period; control: 10 mM 
citrate) and under submerged conditions (for 3 h; control: 
pure medium). Reported are the geometric mean and stand-
ard deviation (n>3). None of the responses was statistically 
significant below 1.0 μg/cm2. For larger doses, significant dif-
ferences between ALICE and submerged responses were 
observed.
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confirmed by the unaffected viability of human alveolar
epithelial A549 cells after ALICE exposure (Figure 8). Fur-
thermore, none of the ZnO nanoparticle doses applied
here had any significant effect on cell viability, which is a
pre-requisite for reliable measurements of particle-
induced oxidative stress response, as performed in the cur-
rent study.
In contrast to jet nebulizers or ultrasonic generators,
vibrating membrane nebulizers do not exert high shear
forces and do not heat the nebulized liquid during the
generation process. Hence, it does not jeopardize the bio-
logical activity of potentially delicate therapeutic agents,
such as biopharmaceuticals [23,38]. Other positive
aspects of the eFlow technology are the low residual vol-
ume in the reservoir (5%-10%), the large and stable mass/
volume output (80-130 mg/m3 for 5 liter/min flow rate)
and the low electrostatic charging of the droplets. Further-
more, the near micron-sized membrane pores may pro-
hibit supermicron particles and nanoparticle
agglomerates to exit the nebulizer. This could explain the
measured reduced deposition efficiencies (0.3-0.4) for
ZnO nanoparticle suspensions, which were not freshly
prepared prior to nebulization. The prolonged residence
time of the ZnO nanoparticles in suspension allowed for
enhanced agglomeration (as confirmed by DLS measure-
ments) leading to supermicron-sized agglomerates, which
were too large to pass through the pores of the nebulizer
membrane. Due to the increasing interest in the pharma-
cological and toxicological effects of nanoparticles, the
prevention of large agglomerates of nanoparticles from
getting delivered to the cells may be an attractive feature
of the ALICE, which comes at the expense of reduced dep-
osition efficiency (less than 0.57 ± 0.07).
The QCM is a highly sensitive, fast-response instrument
for real-time determination of the deposited substance
mass on the cells. The QCM has a response time of ~1 s, a
large dynamic range (0.018-1800 μg/cm2; extendable to
larger mass with non-linear correction factors) and high
accuracy (here: <7.3% agreement with gravimetry). Its
drawback for droplet measurements is that the QCM is
sensitive to viscoelastic effects, which requires drying of
the deposited droplets for accurate determination of the
deposited nanoparticle/solute mass. However, the current
study has shown that the QCM can be used as a real-time
indicator for droplet deposition as long as the deposited
liquid layer induces a frequency shift (QCM signal) of less
than 715 Hz, the asymptotic value of an ''infinitely'' thick
water layer. Finally, it must be stipulated that for stabi-
lized nanoparticle suspensions, the (dry) nanoparticle
mass can only be obtained from the QCM data, if the
mass ratio of nanoparticles and stabilizing agent is
known.
The repeatability of 12% in mass dose delivery is similar
to the value of about 10% reported for the spray exposure
unit RHINOCON ([19]; error bar of the mean deposition
in their figure 2). The entire area of the ALICE chamber
can be used for cell exposure experiments, since the spatial
variability of the ALICE is small (better than 1.6%). For
comparison, the spatial variability of the RHINOCON
system was 8% [19], which is probably due to the less uni-
form spray produced by commercially available spray
units. In spite of excellent uniformity in the ALICE,
agglomeration of nanoparticles, both prior and after neb-
ulization of unstable nanoparticle suspensions, cannot be
ruled out. Hence, for unstable nanoparticle suspensions
the authors recommend minimization of potential
agglomeration by reducing the processing time (less time
for agglomeration), choosing low nanoparticle concentra-
tions (less collision probability) and providing visual con-
firmation of spatial uniformity following nebulization
(TEM measurements).
Although the deposition efficiency in the exposure cham-
ber of the ALICE is relatively large (0.57 ± 0.07), the cell-
specific deposition efficiency is currently limited to 0.072
(for two 6-well plates) due to the poor fractional cell cov-
erage of standard transwell plates. For comparison with
previously described cell exposure systems, it is important
to note that the deposition efficiency of 0.072 represents
the overall deposition efficiency, which is defined as the
ratio of cell deposited and total mass of the substance
filled into the nebulizer. Previous studies typically
reported the internal deposition efficiency, the fractional
deposition of the substance entering the exposure system,
which does not account for reduced overall deposition
efficiency due to, for example, residual substance in the
nebulizer (particle generator) or substance loss in the con-
ductive tubing upstream of the exposure chamber. The
overall deposition efficiency is the more relevant parame-
ter for materials, which are expensive or in limited supply
(e.g. modern drugs), since it provides the basis for esti-
mating the true costs of exposure experiments.
Unfortunately, previous exposure systems have either not
been characterized in terms of deposition efficiency (no
deposition efficiencies are given for any of the cell expo-
sure systems for liquid substances described in the litera-
ture [18-20]) or the reported deposition efficiencies refer
to the internal deposition efficiency, that is it discards
residual material in the particle generator or losses
upstream of the exposure system. For purely diffusion-
based cell exposure systems, the internal deposition effi-
ciencies were limited to 0.02 (relative to the dose entering
the exposure system). Internal deposition efficiencies near
unity (100%) were reported for electrostatic deposition of
charged particles. Stevens and coworkers [33] deposited
size-selected charged particles by passing the aerosolPage 14 of 17
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ferential mobility analyzer (DMA). Since the charging effi-
ciency of a bipolar charger is limited to about 0.30 [21],
the overall deposition efficiency is limited to about 0.3.
For the bipolar electrostatic deposition system by Savi and
coworkers [16], deposition efficiencies of 0.15-0.30 were
reported. However, all of these values are upper limits for
the overall deposition efficiency, since they do not
account for additional losses due to, for example, residual
mass in the particle generator (which can be large depend-
ing on the particle generator), losses in the transport lines
and waste material during turn-on/turn-off phase of the
exposure system. Hence, the overall deposition efficiency
of 0.072 for the ALICE is better than, or within the range
of, typically reported upper limits of overall deposition
efficiencies for air-liquid cell exposure systems.
After nebulization of 1 mL of liquid, a 14 μm liquid layer
is formed on the cells in the ALICE. Since the layer thick-
ness is small compared to the diameter of the transwell
inserts for the cells (>6.4 mm for standard 6-, 12-, and 24-
well plates), nearly 100% of the nanoparticles (or solute
molecules) interact with the cells due to diffusional
motion and diffusional losses to lateral walls are small.
Furthermore, in vivo epithelial cells are typically covered
by a thin liquid layer. Hence, generation of a thin liquid
film on the ALICE cells prevents evaporation of liquid
from the cells and resembles physiological conditions,
especially since the thickness of the deposited film can be
regulated by epithelial cells via water transport to the
basal side [39].
Although the nebulizer used in the current study can spray
up to 5 mL of liquid per filling, the authors recommend
using 1 mL for the following reasons: The QCM can be
used as real-time indicator for 1 mL, or less, of sprayed liq-
uid (frequency shift <715 Hz), the deposited liquid layer
is sufficiently thin (14 μm) for efficient nanoparticle-cell
interaction and the corresponding exposure time is short
(5 min, which increases by about 2 min per additionally
sprayed mL of liquid). Using less liquid reduces the liquid
layer thickness and exposure time, but it also enhances the
residual liquid fraction remaining in the nebulizer (0.05-
0.1 mL; 10-20% for 0.5 mL) and hence the cell deposition
efficiency.
The suitable concentration range of the nanoparticle sus-
pension used in the ALICE is determined by the detection
limit of the QCM. For nebulization of 1 mL of liquid, the
lower detection limit of the QCM (0.018 μg/cm2) corre-
sponds to a solute/nanoparticle concentration of 12.4
ppm (mass) in water. Assuming a maximum solute/nan-
oparticle concentration of 10%, a dose of 160 μg/cm2 per
ALICE run can be supplied to the cells. The lowest concen-
tration applied in the ALICE as yet, was 40 ppm of 15 nm
gold nanoparticles, which resulted in a dose of 0.061 μg/
cm2 (Figure 7). This dose level and a 10-fold higher dose
were used by Brandenberger and coworkers who applied
the ALICE to study cellular uptake and toxicological
effects of a triple cell co-culture model simulating the alve-
olar lung epithelium due to gold nanoparticle exposure at
the air-liquid interface [40].
Although air-liquid interface exposures have become
more widely used in recent years, there are very few quan-
titative comparisons between air-liquid interface and sub-
merged (conventional) dose-response curves after
nanoparticle exposure. Since the ALICE provides direct
accurate dose measurements, the data set provided here
can be used for such a comparison. For both exposure
conditions, A549 cells showed no significant response in
IL-8 and HO-1 mRNA expression after exposure to less
than 1.0 μg/cm2 ZnO nanoparticles (Figure 9). In contrast,
significant differences between exposure methods were
observed for larger concentrations. For the highest inves-
tigated dose (submerged: 5.0 μg/cm2; ALICE: 8.5 μg/cm2),
the ratio of ALICE and submerged response was 0.26 and
5.7 for IL-8 and HO-1, respectively. This indicates a sub-
stantially mitigated and enhanced response for the ALICE
relative to submerged conditions for the pro-inflamma-
tory (IL-8) and oxidative stress marker (HO-1), respec-
tively. The underlying reasons for these differences are
currently unknown.
To put the dose levels obtained during in vitro exposures
(ALICE: 0.3 - 8.5 μg/cm2; submerged: 0.75 - 5 μg/cm2)
into perspective, it is instructive to consider that the cur-
rent recommended Occupational Safety and Health
Administration (OSHA) standard for ZnO fumes is 5 mg
of ZnO per cubic meter of air (5 mg/m3) averaged over an
eight hour work shift. Assuming an accumulated breath-
ing volume of 3 m3 in 8 h, a lung surface area of 140 m2,
an alveolar deposition efficiency of 10-50% (depending
on particle size) and a 70% long-term clearance from the
alveolar regime [41] the OSHA standard corresponds to
an average (long-term) daily alveolar surface dose of 0.32-
1.6 ng/cm2. Hence, the maximum lifetime dose accumu-
lated by a worker is 3.6-18 μg/cm2 (5 workdays per week
for 50 weeks per year over 45 years). The upper limits used
for the current in vitro experiments are within this lifetime
range and the lowest submerged dose of 0.75 μg/cm2 still
corresponds to several years of exposure at the maximum
allowed dose level. Since no significant in vitro cellular
response was observed after challenging the A549 cells
with 0.75 μg/cm2 (for 3 h post-incubation time), the cur-
rent data suggest that ZnO nanoparticles do not pose a sig-
nificant health risk, if the OSHA exposure limits are
obeyed. However, it is unclear whether this result also
holds for a chronic exposure scenario, that is continuous
delivery of the mean daily dose (0.32-1.6 ng/cm2) over a
lifetime.Page 15 of 17
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The air-liquid interface cell exposure system (ALICE)
allows uniform, efficient and dose-controlled deposition
of solutions and nanoparticles in liquids on cell systems.
The ALICE is a closed system suitable for up to two com-
mercially available cell culture plates, which can be oper-
ated by a technical assistant without expert knowledge in
aerosol technology. The deposition mechanism of the
ALICE is based on gravimetric sedimentation, which sim-
ulates the in vivo conditions in the alveolar region. The
pore size of the nebulizer membrane limits the size of the
cell deposited nanoparticles (agglomerates) to about 1 μ
m. Although the ALICE was used here for a cell line, it is
also applicable to other types of biological material such
as tissue sections or even microorganisms.
Cell exposure in the ALICE had no adverse effect on the
viability of a widely used alveolar epithelial cell line
(A549) for the recommended amount of liquid to be
sprayed (1 mL). Dose delivery was repeatable (12%), uni-
form (<1.6% spatial variability) and occurred at a total
(net) cell-specific deposition efficiency of up to 0.072 (for
two 6-well plates). While this may seem small, it exceeds
the total deposition efficiency obtained with most other
exposure systems, if one includes all possible losses in the
balance including residual liquid in the nebulizer, trans-
port losses and losses during the turn-on/turn-off phase.
Currently, the deposition efficiency of the ALICE is mainly
limited by the low fractional cell coverage of standard
transwell plates. For ideal cell coverage (100%) in the
exposure chamber, the deposition efficiency can be
improved to 0.57.
Dose-measurements with a quartz crystal microbalance
(QCM) allow fast (~10 min for exposure and mass deter-
mination) and accurate (<7.3%) determination of the cell
deposited dose. For the recommended 1 mL of sprayed
liquid, a single ALICE exposure can provide 0.02-200 μg/
cm2 of substance to the cells depending on the mass con-
centration of the nanoparticles/solute (0.0012-12%).
The applicability of the ALICE to obtain dose-response
curves was demonstrated by exposing A549 cells to vari-
ous doses of ZnO nanoparticles. The mRNA expression of
the pro-inflammatory cytokine IL-8 and the oxidative
stress marker HO-1 indicated substantial differences
depending on the exposure method (submerged versus
air-liquid interface) for doses larger than 1 μg/cm2. How-
ever, both methods suggest that ZnO nanoparticles are
not toxic, if occupationally allowed exposure levels are
obeyed.
The small amount of liquid to be used (1 mL), the gentle
method of droplet generation, the realistic deposition
process (for the alveolar region) as well as the competitive
deposition efficiency (0.072) make the ALICE a useful in
vitro tool for pharmacological and toxicological studies
for a wide variety of substances including newly devel-
oped expensive and/or delicate drug formulations for e.g.
gene transfer therapy.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
GAF, BL, HS, EK and OS designed the exposure chamber,
AGL, GAF, OS, EK conceived and designed the experi-
ments; AGL, GAF, BL, VD, and CB performed experi-
ments; AGL, EK and OS performed data analysis; AGL, CB,
BRR, and OS made substantial contributions to writing
the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
We would like to thank Mr. Bukalis and Mrs. Alber from the Helmholtz-
Centre Berlin for Materials and Energy for determining the mass of the gold 
nanoparticles deposited in the ALICE using neutron activation analysis. We 
are grateful to Helga Hinze-Heyn and Gabriele Schumann for their excel-
lent technical assistance and Kirsten Dobson for proof reading the English.
This study was supported by grants from the Animalfree Research Founda-
tion, the Doerenkamp-Zbinden Foundation and the Helmholtz Association.
References
1. Peters A, Wichmann H-E, Tuch T, Heinrich J, Heyder J: Respiratory
effects are associated with the number of ultrafine particles.
Am J Respir Crit Care Med 1383, 155(4):1376-1997.
2. Behra R, Krug H: Nanoecotoxicology: Nanoparticles at large.
Nature Nanotechnology 2008, 3(5):253-254.
3. Kreyling WG, Semmler-Behnke M, Möller W: Health implications
of nanoparticles.  Journal of Nanoparticle Research 2006, 8:543-562.
4. Maynard AD, Kuempel ED: Airborne nanostructured particles
and occupational health.  Journal of Nanoparticle Research 2005,
7(6):587-614.
5. Patton JS, Platz RM: Pulmonary delivery of peptides and pro-
teins for systemic action.  Advanced Drug Delivery Reviews 1992,
8(2-3):179-196.
6. Sanjar S, Matthews J: Treating systemic diseases via the lung.
Journal of Aerosol Medicine-Deposition Clearance and Effects in the Lung
2001, 14:S51-S58.
7. Smola M, Vandamme T, Sokolowski A: Nanocarriers as pulmo-
nary drug delivery systems to treat and to diagnose respira-
tory and non respiratory diseases.  Int J Nanomedicine 2008,
3(1):1-19.
8. Maier KL, Alessandrini F, Beck-Speier I, Hofer TP, Diabate S, Bitterle
E, Stoger T, Jakob T, Behrendt H, Horsch M, Beckers J, Ziesenis A,
Hultner L, Frankenberger M, Krauss-Etschmann S, Schulz H: Health
effects of ambient particulate matter--biological mecha-
nisms and inflammatory responses to in vitro and in vivo par-
ticle exposures.  Inhal Toxicol 2008, 20(3):319-37.
9. Kim YM, Reed W, Lenz AG, Jaspers I, Silbajoris R, Nick HS, Samet JM:
Ultrafine carbon particles induce interleukin-8 gene tran-
scription and p38 MAPK activation in normal human bron-
chial epithelial cells.  Am J Physiol Lung Cell Mol Physiol 2005,
288(3):L432-41.
10. Limbach LK, Li YC, Grass RN, Brunner TJ, Hintermann MA, Muller M,
Gunther D, Stark WJ: Oxide nanoparticle uptake in human lung
fibroblasts: Effects of particle size, agglomeration, and diffu-
sion at low concentrations.  Environmental Science & Technology
2005, 39(23):9370-9376.
11. Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG: Parti-
cokinetics in vitro: Dosimetry considerations for in vitro nan-
oparticle toxicity assessments.  Toxicological Sciences 2007,
95(2):300-312.Page 16 of 17
(page number not for citation purposes)
Particle and Fibre Toxicology 2009, 6:32 http://www.particleandfibretoxicology.com/content/6/1/32Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
12. Waters KM, Masiello LM, Zangar RC, Tarasevich BJ, Karin NJ,
Quesenberry RD, Bandyopadhyay S, Teeguarden JG, Pounds JG,
Thrall BD: Macrophage responses to silica nanoparticles are
highly conserved across particle sizes.  Toxicol Sci 2009,
107(2):553-69.
13. Bitterle E, Karg E, Schroeppel A, Kreyling WG, Tippe A, Ferron GA,
Schmid O, Heyder J, Maier KL, Hofer T: Dose-controlled expo-
sure of A549 epithelial cells at the air-liquid interface to air-
borne ultrafine carbonaceous particles.  Chemosphere 1790,
65(10):1784-2006.
14. Aufderheide M, Mohr U: CULTEX - an alternative technique for
cultivation and exposure of cells of the respiratory tract to
airborne pollutants at the air/liquid interface.  Experimental and
Toxicologic Pathology 2000, 52(3):265-270.
15. Fiegel J, Ehrhardt C, Schaefer UF, Lehr CM, Hanes J: Large porous
particle impingement on lung epithelial cell monolayers -
Toward improved particle characterization in the lung.  Phar-
maceutical Research 2003, 20(5):788-796.
16. Savi M, Kalberer M, Lang D, Ryser M, Fierz M, Gaschen A, Ricka J,
Geiser M: A novel exposure system for the efficient and con-
trolled deposition of aerosol particles onto cell cultures.  Envi-
ronmental Science & Technology 2008, 42(15):5667-5674.
17. Grainger CI, Greenwell LL, Martin GP, Forbes B: The permeability
of large molecular weight solutes following particle delivery
to air-interfaced cells that model the respiratory mucosa.
European Journal of Pharmaceutics and Biopharmaceutics 2009,
71(2):318-324.
18. Schreier H, Gagne L, Conary JT, Laurian G: Simulated lung trans-
fection by nebulization of liposome cDNA complexes using a
cascade impactor seeded with 2-CFSMEo-cells.  Journal of Aer-
osol Medicine-Deposition Clearance and Effects in the Lung 1998,
11(1):1-13.
19. Knebel JW, Ritter D, Hoffmann K, Lodding H, Windt H, Koch W,
Aufderheide M: Development and validation of a semiauto-
matic system for generation and deposition of sprays on iso-
lated cells of the respiratory tract.  Toxicology Methods 2001,
11(3):161-171.
20. Blank F, Rothen-Rutishauser BM, Schurch S, Gehr P: An optimized
in vitro model of the respiratory tract wall to study particle
cell interactions.  Journal of Aerosol Medicine-Deposition Clearance and
Effects in the Lung 2006, 19(3):392-405.
21. Hinds WC: Aerosol Technology.  New York, Wiley-Interscience
publications; 1999. 
22. Knoch M, Keller M: The customised electronic nebuliser: a new
category of liquid aerosol drug delivery systems.  Expert Opin
Drug Deliv 2005, 2(2):377-90.
23. Kesser KC, Geller DE: New aerosol delivery devices for cystic
fibrosis.  Respir Care 2009, 54(6):754-68.
24. O'Sullivan CK, Guilbault GG: Commercial quartz crystal micro-
balances - theory and applications.  Biosensors and Bioelectronics
1999, 14(8-9):663-670.
25. Kanazawa K, Gordon JG: The oscillation frequency of a quartz
resonator in contact with liquid.  Analytica Chimica Acta 1985,
175(C):99-105.
26. Lieber M, Smith B, Szakal A: A continuous tumor cell line from a
human lung carcinoma with properties of type II alveolar
epithelial cells.  International Journal of Cancer 1976, 17(1):62-70.
27. Lu SL, Duffin R, Poland C, Daly P, Murphy F, Drost E, MacNee W,
Stone V, Donaldson K: Efficacy of Simple Short-Term in Vitro
Assays for Predicting the Potential of Metal Oxide Nanopar-
ticles to Cause Pulmonary Inflammation.  Environmental Health
Perspectives 2009, 117(2):241-247.
28. Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Bocz-
kowski J, Lacroix G, Hoet P: Comparative toxicity of 24 manu-
factured nanoparticles in human alveolar epithelial and
macrophage cell lines.  Particle and Fibre Toxicology 2009, 6(14):.
doi:10.1186/1743-8977-6-14
29. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi HB, Yeh JI, Zink
JI, Nel AE: Comparison of the Mechanism of Toxicity of Zinc
Oxide and Cerium Oxide Nanoparticles Based on Dissolu-
tion and Oxidative Stress Properties.  Acs Nano 2008,
2(10):2121-2134.
30. Ritter D, Knebel JW, Aufderheide M: In vitro exposure of isolated
cells to native gaseous compounds - Development and vali-
dation of an optimized system for human lung cells.  Experi-
mental and Toxicologic Pathology 2001, 53(5):373-386.
31. Kameyama S, Kondo M, Takeyama K, Nagai A: Air exposure causes
oxidative stress in cultured bovine tracheal epithelial cells
and produces a change in cellular glutathione systems.  Exper-
imental Lung Research 2003, 29(8):567-583.
32. Desantes JM, Margot X, Gil A, Fuentes E: Computational study on
the deposition of ultrafine particles from Diesel exhaust aer-
osol.  Journal of Aerosol Science 2006, 37(12):1750-1769.
33. Stevens JP, Zahardis J, MacPherson M, Mossman BT, Petrucci GA: A
new method for quantifiable and controlled dosage of partic-
ulate matter for in vitro studies:The electrostatic particulate
dosage and exposure system (EPDExS).  Toxicology in Vitro 2008,
22(7):1768-1774.
34. Mülhopt S, Diabate S, Krebs T, Weiss C, Paur H-R: Lung toxicity
determination by in vitro exposure at the air liquid interface
with an integrated online dose measurement. Grenoble
Nanosafe 08 conference proceedings.  Journal of Physics: Confer-
ence Series 2009:170.
35. Bur M, Rothen-Rutishauser B, Huwer H, Lehr CM: A novel cell
compatible impingement system to study in vitro drug
absorption from dry powder aerosol formulations.  European
Journal of Pharmaceutics and Biopharmaceutics 2009, 72(2):350-357.
36. Mülhopt S, Paur HR, Diabate S, Krug HF: In vitro testing of inhal-
able fly ash at the air-liquid interface.  In Advanded environmental
monitoring Edited by: Kim YJ, Platt U. Netherlands, Springer;
2007:402-414. 
37. Heyder J, Gebhart J, Rudolf G, Schiller CF, Stahlhofen W: Deposi-
tion of particles in the human respiratory tract in the size
range 0.005 - 15 micron.  Journal of Aerosol Science 1986,
17(c):811-825.
38. Wagner A, Vorauer-Uhl K, Katinger H: Nebulization of liposomal
rh-Cu/Zn-SOD with a novel vibrating membrane nebulizer.
J Liposome Res 2006, 16(2):113-25.
39. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P: Molecu-
lar Biology of the Cell.  Garland Science 2002.
40. Brandenberger C, Rothen-Rutishauser B, Mühlfeld C, Schmid O, Fer-
ron GA, Maier KL, Gehr P, Lenz A-G: Effects and uptake of gold
nanoparticles deposited at the air-liquid interface of a
human epithelial airway model.  Toxicology and Applied Pharmacol-
ogy 2010, 242(1):56-65.
41. Kreyling WG, Scheuch G: Clearance of particles deposited in
thelungs.  In Particle-Lung Interactions Edited by: Gehr P, Heyder J.
New York, Basel, Marcel Dekker Inc; 2000:323-376. Page 17 of 17
(page number not for citation purposes)
